LYONS GARY A
Director · 3 filings · Latest: May 27, 2026
NEUROCRINE BIOSCIENCES INC
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBIX | LYONS GARY A | Director | May 21, 2026 | Option Exercise | $0.00 | 1,659 | — | 122,141 |